For the purpose of identifying active bone lesions, 99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice. There are numerous mechanisms that have been reported to lead to extraosseous radiopharmaceutical uptake on bone scintigraphy that must be understood in order to ascertain the underlying cause. Since these unexpected distributions of radiotracer activity on bone scintigraphy frequently result from technical causes, artifacts, and pitfalls related to quality control, the first step when these findings appear on the bone scan is to confirm or rule out these factors. In addition, they might affect other scans that department performed that day (for instance, colloid impurities caused by aluminum breakthrough in the molybdenum-technetium generator during 99mTc-MDP preparation could affect a wide range of radionuclide studies). It is mostly used to find bone damage caused by infections and other conditions as well as to help diagnose various bone-related conditions like primary or metastatic bone cancer, the location of bone inflammation, and fractures that may not be visible on traditional X-ray images. On a whole-body bone scan, pathologies of other systems can also be found by accident. In this paper, we present a captivating image of appearance thyroid gland on bone scan.

Euthyroid, Bone Scan, Thyroid Gland, Thyroid Function Tests

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.